Billet Isabelle 4
4 · Axogen, Inc. · Filed Dec 29, 2022
Insider Transaction Report
Form 4
Axogen, Inc.AXGN
Billet Isabelle
Chief Strategy and BD Officer
Transactions
- Tax Payment
Common Stock
2022-12-27$9.44/sh−327$3,087→ 25,065 total - Exercise/Conversion
Restricted Stock Units
2022-12-27+1,150→ 0 total→ Common Stock (1,150 underlying) - Exercise/Conversion
Common Stock
2022-12-27+1,150→ 25,392 total
Footnotes (4)
- [F1]This reflects the number of restricted stock units that vested on December 27, 2022.
- [F2]Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
- [F3]Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock.
- [F4]All shares of AxoGen Inc. common stock underlying the restricted stock units vested on December 27, 2022 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on December 27, 2020 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter.